Vaxcell-Bio Therapeutics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Revenue	1,899	13.72	-	-	-	Upgrade
Revenue Growth (YoY)	13737.28%	-	-	-	-	Upgrade
Cost of Revenue	1,537	10.44	16.43	19.37	5.39	Upgrade
Gross Profit	361.57	3.28	-16.43	-19.37	-5.39	Upgrade
Selling, General & Admin	8,002	6,171	5,793	3,811	2,714	Upgrade
Research & Development	6,040	4,919	2,075	1,810	1,350	Upgrade
Other Operating Expenses	23	20.67	16.62	6.57	0.44	Upgrade
Operating Expenses	15,443	11,510	8,196	5,885	4,250	Upgrade
Operating Income	-15,081	-11,507	-8,213	-5,904	-4,255	Upgrade
Interest Expense	-225.12	-43.66	-16.68	-26.9	-34.9	Upgrade
Interest & Investment Income	2,620	1,155	421.91	322.31	109.72	Upgrade
Currency Exchange Gain (Loss)	-1.51	-11.69	-	-	-	Upgrade
Other Non Operating Income (Expenses)	2,304	259.95	982.37	846.11	196.05	Upgrade
EBT Excluding Unusual Items	-10,384	-10,147	-6,825	-4,763	-3,984	Upgrade
Gain (Loss) on Sale of Investments	-182.7	-126.84	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	-56.65	-	-0.05	-0.25	-	Upgrade
Pretax Income	-10,624	-10,274	-6,825	-4,763	-3,984	Upgrade
Net Income	-10,624	-10,274	-6,825	-4,763	-3,984	Upgrade
Net Income to Common	-10,624	-10,274	-6,825	-4,763	-3,984	Upgrade
Shares Outstanding (Basic)	23	20	15	15	7	Upgrade
Shares Outstanding (Diluted)	23	20	15	15	7	Upgrade
Shares Change (YoY)	17.03%	28.80%	0.68%	122.02%	55.35%	Upgrade
EPS (Basic)	-463.00	-524.00	-448.34	-315.00	-585.00	Upgrade
EPS (Diluted)	-463.00	-524.00	-448.34	-315.00	-585.00	Upgrade
Free Cash Flow	-12,824	-9,589	-6,212	-6,785	-3,330	Upgrade
Free Cash Flow Per Share	-558.88	-489.05	-408.07	-448.78	-488.95	Upgrade
Gross Margin	19.04%	23.90%	-	-	-	Upgrade
Operating Margin	-794.20%	-83851.26%	-	-	-	Upgrade
Profit Margin	-559.45%	-74865.84%	-	-	-	Upgrade
Free Cash Flow Margin	-675.31%	-69872.25%	-	-	-	Upgrade
EBITDA	-13,616	-11,107	-7,901	-5,647	-4,070	Upgrade
D&A For EBITDA	1,466	399.68	311.34	257.25	185.31	Upgrade
EBIT	-15,081	-11,507	-8,213	-5,904	-4,255	Upgrade
Advertising Expenses	409.6	77.55	38.41	2	19.76	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.